Tokyo, Japan In 1999 was created Yasuda Enterprise Development, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the Menlo Park.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Hardware. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Synageva BioPharma, Topica Pharmaceuticals, InPhase Technologies. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Comparing to the other companies, this Yasuda Enterprise Development performs on 10 percentage points more the average number of lead investments. The average startup value when the investment from Yasuda Enterprise Development is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2004. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2013.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Yasuda Enterprise Development, startups are often financed by Oxford Bioscience Partners, Kleiner Perkins, HealthCare Ventures. The meaningful sponsors for the fund in investment in the same round are Japan Asia Investment, HealthCare Ventures, NIF Ventures. In the next rounds fund is usually obtained by Japan Asia Investment, Kleiner Perkins, SMBC Venture Capital.
Related Funds
Funds with similar focus
| Fund Name | Location |
| CEI Community Ventures | Oregon, Portland, United States |
| Cyber Wisdom | China, Hong Kong, Kowloon |
| Esfin Gestion | Courbevoie, France, Ile-de-France |
| Gen3 Partners | Boston, Massachusetts, United States |
| GMH Ventures | Newtown Square, Pennsylvania, United States |
| Gongdao Chuangxin | Beijing, Beijing, China |
| Haitong Kaiyuan Investment | China, Shanghai |
| JFJF Ventures | - |
| Korea Credit Guarantee Fund | Daegu, South Korea, Taegu-jikhalsi |
| Loudwater Investment Partners | England, London, United Kingdom |
| Makeover Solutions | New York, New York, United States |
| Odyssey Investment Partners | New York, New York, United States |
| PlanetM | Lansing, Michigan, United States |
| Ranwa Technologies Co. | - |
| Seed River | - |
| Shangbay Capital | California, Palo Alto, United States |
| Taiwan Tech Arena | - |
| User Local | Japan, Tokyo |
| XFactor Ventures | Boston, Massachusetts, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Topica Pharmaceuticals | $27M | 18 Oct 2011 | Palo Alto, California, United States | ||
Streetmedia | $455K | 14 Dec 2009 | Chiyoda, Japan | ||
| $11M | 03 Sep 2008 | San Francisco, California, United States | |||
REGiMMUNE Corporation | $8M | 06 May 2008 | Chiyoda | ||
REGiMMUNE Corporation | $6M | 01 Feb 2008 | Chiyoda | ||
NanoGram | $32M | 15 Jan 2008 | United States, Milpitas | ||
REGiMMUNE Corporation | $4M | 21 Feb 2007 | Chiyoda, Japan | ||
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
| $13M | 29 Aug 2005 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Topica Pharmaceuticals | $27M | 18 Oct 2011 | Palo Alto, California, United States | ||
Streetmedia | $455K | 14 Dec 2009 | Chiyoda, Japan | ||
| $11M | 03 Sep 2008 | San Francisco, California, United States | |||
REGiMMUNE Corporation | $8M | 06 May 2008 | Chiyoda | ||
REGiMMUNE Corporation | $6M | 01 Feb 2008 | Chiyoda | ||
NanoGram | $32M | 15 Jan 2008 | United States, Milpitas | ||
REGiMMUNE Corporation | $4M | 21 Feb 2007 | Chiyoda, Japan | ||
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
| $13M | 29 Aug 2005 | California, United States |
